Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination. (Q44041891)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 June 2002

Language	Label	Description	Also known as
English	Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.	scientific article published on 25 June 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

lipopolysaccharide

0 references

protein ubiquitination

1 reference

based on heuristic

inferred from title

phosphorylation

1 reference

based on heuristic

inferred from title

Clifford C Taggart

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Catherine M Greene

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Noel G McElvaney

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Shane O'Neill

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

0 references

publication date

25 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

277

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

33648-33653

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Expression of the secretory leukoprotease inhibitor gene in epithelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Distribution of secretory leukoprotease inhibitor in the human nasal airway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Inhibition of NF-kappaB activation and augmentation of IkappaBbeta by secretory leukocyte protease inhibitor during lung inflammation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

The serine protease inhibitor antithrombin III inhibits LPS-mediated NF-kappaB activation by TLR-4.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M203710200

21 January 2018

Identifiers

10.1074/JBC.M203710200

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12084717%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44041891&oldid=2105884486"